The vaccine maker’s shots involve the successful Covid vaccines’ RNA technology. Health Secretary Robert F. Kennedy Jr. has ...

According to Moderna, which used a valuable priority review voucher to speed up the FDA's review, the agency has said that ...

Moderna Inc. (NASDAQ: MRNA) shares declined sharply in after-hours trading on Tuesday after the biotechnology company ...

Friday, February 13th, 2026 As far as economic reports go, the good news just keeps on coming. Seemingly running on a separate track from investor fears about AI’s future role in the economy, today’s ...

Mani Foroohar, M.D., of Leerink Partners, says that the decision reflects “how sharp the departure has been between the prior ...

Vinay Prasad, the Trump administration’s top vaccine regulator at the Food and Drug Administration, single-handedly decided ...

Ethris GmbH, a clinical-stage biotechnology company pioneering next-generation RNA therapeutics and vaccines, and the German Center for Infection Research (Deutsches Zentrum für Infektionsforschung, ...

SSI Diagnostica Group has two complementary portfolios with both Life Science and In Vitro Diagnostics. The company serves three main application areas: vaccine development, disease surveillance, and ...

From vaccines and diagnostics to emerging gene-based therapies, RNA molecules are now central to modern medicine. But as their use continues to grow, so does a fundamental challenge: producing RNA ...

Researchers developed C28, an engineered polymerase that efficiently synthesizes RNA at near-natural speeds with high ...

The Trump administration’s top immigration officials defended their mass deportation efforts in a congressional hearing even as Democrats pressed them to answer questions about fatal shootings of two ...

Moderna (MRNA) came out with a quarterly loss of $2.11 per share versus the Zacks Consensus Estimate of a loss of $2.6. This compares to a loss of $2.5 per share a year ago. These figures are adjusted ...